James Huang, Director, 10% Owner at Atara Biotherapeutics, Inc. (ATRA), bought 38,670 shares at $9.64 ($373K) on 2025-07-17, disclosed to the SEC on 2025-07-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.64 | 19,335 | $186K | 50.0% |
| 2 | $9.64 | 19,335 | $186K | 50.0% |
| Total | $9.64 avg | 38,670 | $373K | 100% |
| Filing → |
| ATRA | SELL | 2026-01-14 | $489K | — | Filing → |
| CASI | BUY | 2022-09-08 | $304K | — | Filing → |
| CASI | BUY | 2022-09-02 | $233K | — | Filing → |